COMMUNIQUÉS West-GlobeNewswire

athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from Administrative Burden

01/03/2018 - 14:00

Also: Sneak Peek Epocrates Connect, A Universal Mobile App Designed to End Industry’s Status Quo EHR Experience and Unleash Unparalleled Access to Clinical Information On Stage: CEO Jonathan Bush Hosts Thomas Jefferson [...]

scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference

01/03/2018 - 14:00

BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]

FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018

01/03/2018 - 14:00

AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) announced today that the U.S. Food and Drug Administration (FDA) has determined that a New Drug Application (NDA) for REMOXY ER, [...]

Spero Therapeutics to Present at March Investor Conferences

01/03/2018 - 14:00

CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Woebot Secures $8 Million in Funding to Increase Access to Mental Health Care Worldwide

01/03/2018 - 13:30

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Today, Woebot Labs, Inc. announced an $8 million Series A funding round from leading venture capital firm New Enterprise Associates (NEA) with participation from Andrew [...]

Otonomy to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update

01/03/2018 - 13:30

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will report financial [...]

BioCorRx Schedules Business Update Conference Call

01/03/2018 - 13:30

ANAHEIM, CA, March 01, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced it will [...]

Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights

01/03/2018 - 13:30

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today reported financial [...]

CareDx to Refinance Debt with Perceptive Advisors

01/03/2018 - 13:30

Balance Sheet to be Simplified with Single Term Loan BRISBANE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and [...]

Myriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness Month

01/03/2018 - 13:05

SALT LAKE CITY, March 01, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary [...]

ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting

01/03/2018 - 13:01

Oral administration of OBE022 shows favorable safety and results in predictable exposure Non-clinical results of OBE022 for PTL demonstrating fetal safety Geneva, Switzerland and Boston, MA - 01 March 2018 - ObsEva SA ( [...]

Shire plc : Director/PDMR Shareholding

01/03/2018 - 13:01

Director/PDMR Shareholding March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet™ Needle-Free Delivery System

01/03/2018 - 13:00

EWING, N.J., March 01, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) today announced that it has received $2.75 million from Ferring Pharmaceuticals (“Ferring”) in connection with the [...]

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 13:00

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Sunesis Pharmaceuticals to Host Conference Call on March 8th to Discuss Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights

01/03/2018 - 13:00

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Thursday, March 8th, 2018 at 1:30 p.m. Pacific Time to [...]

Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8

01/03/2018 - 13:00

REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after [...]

Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial Evaluating IMO-2125 in Combination with Ipilimumab for the Treatment of Anti-PD-1 Refractory Melanoma (ILLUMINATE 301)

01/03/2018 - 13:00

EXTON, Pa. and CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients [...]

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Results

01/03/2018 - 13:00

NASHVILLE, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter [...]

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

01/03/2018 - 13:00

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive ") (TSX-V: RVV ) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and [...]